CAS 1346452-25-2

Enfortumab vedotin-ejfv

CAS: 1346452-25-2

Enfortumab vedotin-ejfv

Reinheit: ≥95%

Ref: 54-BUP20308

Enfortumab vedotin-ejfv

CAS: 1346452-25-2

Enfortumab vedotin-ejfv (Padcev) is an ADC compound targeting Nectin-4 with anti-tumor activity, used in the study of urothelial carcinoma.

Reinheit: 100% (SEC-HPLC) - 96.33% (SEC-HPLC)

Farbe und Form: Liquid

Molekulargewicht: N

Ref: TM-T78065

Enfortumab

CAS: 1346452-25-2

Anti-Human Nectin-4 Monoclonal Antibody

Ref: 3D-CLA1341